Axonics, Inc. short interest in 2023
In 2023, Axonics, Inc.'s disclosed short interest ran from 7.14% of shares outstanding on 13 Jan 2023 to 5.13% on 29 Dec 2023, a change of -2.01 percentage points. The year's high was 8.40% on 14 Apr 2023 and its low 4.27% on 15 Nov 2023, averaging 6.81% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.05 days on 14 Apr 2023. Full history: Axonics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2023 in figures
- Start of year
- 7.14% (13 Jan 2023)
- End of year
- 5.13% (29 Dec 2023)
- Change
- -2.01 pp
- High
- 8.40% (14 Apr 2023)
- Low
- 4.27% (15 Nov 2023)
- Average
- 6.81%
- Highest days to cover
- 10.05 (14 Apr 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 7.14% | 3.05 | results (8-K) |
| 31 Jan 2023 | 7.05% | 6.53 | |
| 15 Feb 2023 | 7.80% | 7.19 | |
| 28 Feb 2023 | 7.93% | 7.26 | |
| 15 Mar 2023 | 7.73% | 5.50 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 8.18% | 5.79 | |
| 14 Apr 2023 | 8.40% | 10.05 | |
| 28 Apr 2023 | 8.17% | 8.66 | |
| 15 May 2023 | 8.26% | 5.05 | results (8-K), 10-Q filed |
| 31 May 2023 | 8.07% | 6.72 | |
| 15 Jun 2023 | 7.99% | 7.95 | |
| 30 Jun 2023 | 7.55% | 6.43 | |
| 14 Jul 2023 | 7.73% | 6.51 | |
| 31 Jul 2023 | 6.94% | 3.29 | results (8-K), 10-Q filed |
| 15 Aug 2023 | 5.70% | 5.00 | |
| 31 Aug 2023 | 6.12% | 4.04 | |
| 15 Sep 2023 | 6.10% | 5.08 | |
| 29 Sep 2023 | 6.16% | 6.90 | |
| 13 Oct 2023 | 5.53% | 4.69 | |
| 31 Oct 2023 | 5.46% | 4.25 | results (8-K), 10-Q filed |
| 15 Nov 2023 | 4.27% | 3.66 | |
| 30 Nov 2023 | 4.60% | 5.91 | |
| 15 Dec 2023 | 5.36% | 5.28 | |
| 29 Dec 2023 | 5.13% | 6.51 |
See also: Axonics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.